{
    "status": "ok",
    "totalResults": 5,
    "articles": [
        {
            "source": {
                "id": null,
                "name": "Yahoo Entertainment"
            },
            "author": "GuruFocus Research",
            "title": "Director Frank Watkins Sells 3,000 Shares of ShockWave Medical Inc",
            "description": "On September 20, 2023, Director Frank Watkins sold 3,000 shares of ShockWave Medical Inc (NASDAQ:SWAV).",
            "url": "https://finance.yahoo.com/news/director-frank-watkins-sells-3-090132798.html",
            "urlToImage": "https://s.yimg.com/ny/api/res/1.2/yGIuOVjIjYVFnPyq4ZO5dQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD01MDY-/https://media.zenfs.com/en/us.finance.gurufocus/3d0740f116dee186de11548995fea616",
            "publishedAt": "2023-09-22T09:01:32Z",
            "content": "On September 20, 2023, Director Frank Watkins sold 3,000 shares of ShockWave Medical Inc (NASDAQ:SWAV). This move comes amidst a year where the insider has sold a total of 40,000 shares and purchased\u2026 [+2120 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "GlobeNewswire",
            "title": "Shockwave Medical to Livestream 2023 Investor Innovation Day",
            "description": "(marketscreener.com) SANTA CLARA, Calif., Oct. 04, 2023 -- Shockwave Medical, Inc. , a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, will host an Investor Innovation Day on\u00a0Monda\u2026",
            "url": "https://www.marketscreener.com/quote/stock/SHOCKWAVE-MEDICAL-INC-55399621/news/Shockwave-Medical-to-Livestream-2023-Investor-Innovation-Day-44981763/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
            "publishedAt": "2023-10-04T12:03:01Z",
            "content": "SANTA CLARA, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of\u2026 [+3751 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Neuro42",
            "title": "neuro42 Receives Direct Investment and Appoints Surgical Robotics Industry Pioneer Fred Moll as Strategic Advisor",
            "description": "SAN FRANCISCO, Oct. 05, 2023 (GLOBE NEWSWIRE) -- neuro42, Inc. (\u201cneuro42\u201d or the \u201cCompany\u201d), a medical technology company leading the next evolution of MRI and robotics, today announced it has received a direct investment from Fred Moll, M.D., industry pionee\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/05/2755656/0/en/neuro42-Receives-Direct-Investment-and-Appoints-Surgical-Robotics-Industry-Pioneer-Fred-Moll-as-Strategic-Advisor.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/eb94ad93-078e-4a27-aca2-1d790881e95b",
            "publishedAt": "2023-10-05T16:00:00Z",
            "content": "SAN FRANCISCO, Oct. 05, 2023 (GLOBE NEWSWIRE) -- neuro42, Inc. (neuro42 or the Company), a medical technology company leading the next evolution of MRI and robotics, today announced it has received a\u2026 [+2484 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Promaxo, Inc.",
            "title": "Promaxo Receives Direct Investment from Surgical Robotics Industry Pioneer Fred Moll and Announces Appointment as Strategic Advisor",
            "description": "OAKLAND, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Promaxo, Inc. (\u201cPromaxo\u201d or the \u201cCompany\u201d), a medical imaging, robotics, and AI technology company, announced today that it has received a direct investment from Fred Moll, M.D., industry pioneer and leader i\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/04/2754830/0/en/Promaxo-Receives-Direct-Investment-from-Surgical-Robotics-Industry-Pioneer-Fred-Moll-and-Announces-Appointment-as-Strategic-Advisor.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/cf9a329b-5cca-4187-813f-0a83a737a6f7",
            "publishedAt": "2023-10-04T16:00:00Z",
            "content": "OAKLAND, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Promaxo, Inc. (Promaxo or the Company), a medical imaging, robotics, and AI technology company, announced today that it has received a direct invest\u2026 [+2595 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research Nester",
            "title": "Extracorporeal Shock Wave Lithotripsy Market revenue to surpass USD 1 Billion by 2035, says Research Nester",
            "description": "Prominent extracorporeal shock wave lithotripsy (ESWL) market players include Siemens AG, Boston Scientific Corporation, C.R. Bard Inc., Cook Group Inc., Medtrue Enterprise Co. Ltd., Jiangsu Sainty Handsome Co., Ltd., Lumenis LTD., Olympus Corporation, Dornie\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/21/2747055/0/en/Extracorporeal-Shock-Wave-Lithotripsy-Market-revenue-to-surpass-USD-1-Billion-by-2035-says-Research-Nester.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/77e335b1-e272-4a4c-a0ff-211ce0caee29",
            "publishedAt": "2023-09-21T09:30:00Z",
            "content": "New York, Sept. 21, 2023 (GLOBE NEWSWIRE) -- The global extracorporeal shock wave lithotripsy market size is predicted to expand at ~6% CAGR between 2023 and 2035. The market is projected to garner a\u2026 [+8395 chars]"
        }
    ]
}